glp 1 agonists for obesity GLP-1 In Science Behind GLP 1 GIP

Sui X, Jiang S, Zhang H, Wu F, Wang H, Yang C et al (2024) Extended fasting and thyroid hormone regulation

In the foundational study by Raun et al

The side effects of GIP/GLP-1 receptor agonists are most commonly gastrointestinal with nausea, vomiting, diarrhoea, constipation, but similar in severity and frequency to GLP-1 agonists [9]

Advances in the understanding of mitochondrial DNA as a pathogenic factor in inflammatory diseases

The glucocorticoidss excess led to myopathy, osteoporosis, diabetes, and hypertension, among other diseases

Therapeutic and pharmacological potential for improving a drugs bioavailability, effectiveness, and selectivity was demonstrated by nanoparticles